Medical Spa & Aesthetics Practice Software
The buyer population — Other personal care services
Base industry report for 812190 →- Establishments · CanadaA
- 4,263
- Under 10 employeesA
- 83%
Of 4,263 Canadian establishments with employees, 83% have fewer than ten — an industry of very small operators. Each of those is one potential account, before any filter for size or fit.
Entry signal — what decides who wins here
One thing must be trueEntry turns on a single condition that can be named and tested before much is spent. Clear it and this becomes an execution question; fail it and no amount of operating skill helps.
Displace an incumbent the screen found well defended — payments attached to the workflow, data that does not leave, a contract that renews itself. Share here means giving a buyer a reason to break something that currently works, which is a higher bar than being better.
Measured, not forecast: the share of US establishments opening in one year that were still active later. It counts good operators and bad ones together, which is exactly why it is the honest answer to “what are the odds”. It is for the whole sector rather than this market, and the ten-year figure comes from an older cohort because no younger one has reached ten years.
This is not a probability of success, and it is not a verdict on you. No survival probability is published per market, and inventing one would be worse than saying so. What the bar reads is how much of the outcome sits inside an operator's control: green means the hurdles are ones a better operator clears, red means the binding constraint is capital, an asset or a permission rather than execution. Someone arriving with an advantage this screen did not assume can win a market shown in red.
Companies named in this market · 11
The binding constraint — incumbent vulnerability
Medspas straddle two codes. They are filed here under 812190 (other personal care services), but the injecting, prescribing and supervising happen under a medical director, which is physicians'-office work (621111). The software follows that split. How this differs from salon and spa software (812115): the salon stack is booking, staff, retail and payments. A medspa needs all of that plus a clinical record. That means injectable charting on a face map with units, product and lot numbers; signed treatment consents; before-and-after photos; good-faith exams and medical-director sign-off; e-prescribing; and memberships and loyalty programs that sell treatment packages ahead of time. The customer is also different. AmSpa counted 10,488 US medspas in 2023, up from 8,899, averaging about $1.4M in revenue each; 81% are single-location, and 67% of single-owner practices are owned by non-physicians [B, association survey]. That is a larger ticket than a salon, and the owner carries medical liability. There is no single incumbent; two camps meet in the middle. On the clinical side, PatientNow (owned by PSG; 5,000+ locations claimed), Aesthetic Record (9,000+ clinics claimed) and AestheticsPro (claims nearly 30% of US and Canadian medspas) sell an aesthetics EMR with booking attached. Nextech, which TPG bought for $1.4B in 2023 [B], covers the surgeon and dermatologist end. On the salon-platform side, Boulevard ($80M Series D led by JMI Equity, July 2025, about $800M valuation, about $188M raised) says medspas are its fastest-growing segment and that it powers about 15% of US medspas [B; share C]. Zenoti (about $331M raised, valued near $1.5B in 2021) [B] and Mangomint (about $48M) [B] sell medspa editions of their salon software. The vendor claims add up to more clinics than AmSpa counts, so the shares overlap or are inflated. The obvious wedges are already funded. Moxie ($51M total; $25M Series C led by Viewpoint Ventures, March 2026) [B] bundles EMR, compliance, medical-director matching and coaching for a share of practice sales, which is closer to a franchise or management company than to SaaS. RepeatMD ($50M Series A including $10M of debt, co-led by Centana Growth Partners and Full In Partners, November 2023) [B] owns memberships, rewards and e-commerce as an add-on that plugs into the EMRs. PatientNow bought Recura (an AI receptionist) in November 2025 [B]. A new entrant would face PE-owned EMRs, three venture-funded booking platforms that already process medspa payments, and funded specialists in the two places a newcomer would start: compliance and memberships. Incumbent vulnerability decides it. No vendor publishes revenue.
The incumbent
Who owns this market and who is coming for it. Fields a screen never reached say so rather than guessing.
Financials & market size — sourced
Figures that came from a filing, a results release or reputable reporting, each carrying its evidence tier.
The field
Every vendor named on this record, and what each one discloses. Most disclose nothing, which is why the market is not sized.
Competitor set · 10 named · 0 disclose revenue
| Name | Revenue | Share | Note |
|---|---|---|---|
| PatientNow (RxPhoto, Recura)B | not disclosed | — | Aesthetics EMR, scheduling, payments, marketing and photo documentation; claims 5,000+ active locations [C]. Owned by PSG, which advised on its November 2025 acquisition of Recura AI (AI medspa receptionist) [B]. No revenue published |
| Aesthetic RecordC | not disclosed | — | Aesthetics EMR and practice management built around injectable charting; claims 9,000+ clinics, 78,000+ users, 3.5M patients [C]. Founded by a physician; no outside funding round found |
| AestheticsProC | not disclosed | — | Cloud medspa EMR, founded 2007, Olympia, Washington; claims to serve 'nearly 30% of medical spas in the US and Canada' [C]. Independent; no funding disclosed |
| BoulevardB | not disclosed | — | Salon-and-spa platform whose fastest-growing segment is medspas; $80M Series D led by JMI Equity (July 2025) at about $800M, about $188M raised since 2016; says it powers ~15% of US medspas and processes ~$5B a year [B; claims C] |
| ZenotiB | not disclosed | — | Salon, spa, medspa and fitness platform; $160M Series D led by Advent International (December 2020) and an $80M TPG-led extension (June 2021) at about $1.5B; about $331M raised [B]. Claims 30,000+ businesses across all its verticals [C]. Its scale figures are on the 812115 record |
| MoxieB | not disclosed | — | Medspa operating platform: EMR, payments, memberships and inventory software, plus compliance, medical-director matching and coaching, paid as a share of practice sales. $51M raised in total, most recently a $25M Series C led by Viewpoint Ventures (March 2026) with SignalFire, Lachy Groom and Haystack [B]; 700+ practices claimed [C] |
| RepeatMDB | not disclosed | — | Branded patient app for memberships, rewards, e-commerce and financing that plugs into the practice's existing EMR. Houston, launched 2021; $50M Series A (including a $10M SVB debt facility) co-led by Centana Growth Partners and Full In Partners, November 2023 [B]; claims 4,000+ practices [C] |
| MangomintB | not disclosed | — | Salon and spa software with a medspa edition; Los Angeles; $13M Series A led by OpenView (December 2022) and $35M Series B led by Altos Ventures (September 2024) [B] |
| NextechB | not disclosed | — | Specialty-physician EHR and practice management for plastic surgery, dermatology, medspa, ophthalmology and orthopaedics; TPG agreed to buy it from Thomas H. Lee Partners for $1.4B (July 2023); 11,000+ physicians [B]. It sits at the 621111 end of the straddle |
| PabauC | not disclosed | — | UK all-in-one clinic software for aesthetics and medical practices; claims 4,000+ practices worldwide [C]. No funding round found |
Nobody here publishes revenue. The market is not sized for that reason — an estimate built on nothing would only look like knowledge.
Startups & challengers
Newer and smaller vendors going at the incumbent — funded challengers first. Named, not researched to the depth of the field above; a company with a page here links to it.
| Company | Stage | What it does | Raised |
|---|---|---|---|
| Prospyr | Startup | Practice management for medspas and aesthetic clinics | — |
Evidence
Evidence. Opened 2026-10-08. Medspa counts, average revenue, the single-location share and non-physician ownership come from AmSpa's 2024 Medical Spa State of the Industry recap on americanmedspa.org [B, association survey]. Boulevard: TechCrunch, 2025-07-17 ($80M Series D, JMI Equity, ~$800M valuation, ~15% of US medspas, ~$5B processed) [B; share and volume are the company's, C]; Crunchbase News (2025-07-17) confirms the round and about $188M raised since 2016 [B]. Zenoti: Inc42 (June 2021, $80M TPG, $1.5B, ~$331M total, $160M Advent Series D in December 2020) [B]. Moxie: AmSpa news post of the Series C release (2026-03-10, $25M, Viewpoint Ventures, $51M total, 700+ practices) [B for the round; counts C]; TechCrunch 2024-09-24 (Series B led by Lachy Groom with SignalFire; revenue-share model; competitors include LaserAway and PE chains) [B]. The Series A is reported inconsistently ($11.9M in one search summary, $15.7M in TechCrunch's total), so only the $51M total is used. RepeatMD: InnovationMap Houston, 2023-11-27 [B]; businesswire.com returned 403. PatientNow: Weil's deal note (PSG portfolio company acquired Recura AI, announced 2025-11-03) [B]; the 5,000+ location count is from patientnow.com [C]. Nextech: Healthcare Dive (TPG, $1.4B, Thomas H. Lee Partners, 11,000+ physicians, medspa among its specialties) [B]; Fierce Healthcare returned 403. Mangomint: TechCrunch 2022-12-19 ($13M Series A, OpenView) and 2024-09-06 ($35M Series B, Altos Ventures) [B]. Aesthetic Record, AestheticsPro and Pabau customer counts are from their own sites [C]; no funding round was found for any of them. Aesthetic Record's reported $1B+ in annual payments and its 2026 JOYA Health acquisition appeared only in search summaries and were NOT opened. Vendor revenue and market share UNVERIFIED — no vendor publishes revenue, and the vendor share claims overlap.
Where the industry talks
The associations, forums and events where people in this trade actually talk shop — where to listen before entering, and where the first customers are found. Each link was opened on the date shown.
Legal, compliance and business resources for medical aesthetic practices; says it serves 15,000+ medical spas across 50 states (more than its own 10,488 industry count, so read it as reach, not membership); publishes the annual Medical Spa State of the Industry report
AmSpa's annual show; 2027 edition April 15-18, Wynn Las Vegas
Society of board-certified aesthetic plastic surgeons; its gallery lists 2,200+ surgeons (not stated as a member count). Represents the physician end of the 812190/621111 straddle
Professional body for doctors practising aesthetic medicine, about 470 members; 2027 conference announced
Clinical and practice-development publication covering injectables, energy devices, skincare and surgical aesthetics
The Canadian Association of Aesthetic Medicine (caam.ca) refused the connection and is not listed. MedEsthetics magazine (medestheticsmag.com) returned 403, and medesthetics.com is a parked domain.